Immuno-oncology company Affimed N.V. (AFMD) announced Tuesday that Shawn Leland has been appointed as Chief Executive Officer (CEO). Andreas Harstrick, who has been serving as acting CEO since January 2024 will continue in his position as Chief Medical Officer (CMO).
Leland is an accomplished pharmaceutical and biotechnology professional with more than 15 years of experience in the industry. Most recently, Leland was the Interim CEO and Board Director of ForeBio.
In July 2019, Leland founded Elevation Oncology and initially took on the roles of Chief Business Officer and Board Director, later transitioning to CEO until January 2023.
Leland was Head of Business Development at Verastem Oncology from 2017 to 2019 and held a similar position at Argos Therapeutics from 2013 to 2017. He began his career with ARIAD Pharmaceuticals and Eli Lilly, where he gained valuable experience in the pharmaceutical and biotechnology sector.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.